Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results
Feb 21, 2017 12:01 pm UTC| Business
CAMBRIDGE, Mass., Feb. 21, 2017 -- Momenta Pharmaceuticals,Inc. (Nasdaq:MNTA) today reported its financial results for the fourth quarter and year ended December 31, 2016. For the fourth quarter of 2016, the Company...
Astec Industries Reports Fourth Quarter and 2016 Results
Feb 21, 2017 12:01 pm UTC| Business
CHATTANOOGA, Tenn., Feb. 21, 2017 -- Astec Industries, Inc. (Nasdaq:ASTE) today reported results for their fourth quarter and year ended December 31, 2016. Net sales for the fourth quarter of 2016 were $326.6 million...
Astec Industries Reports Fourth Quarter and 2016 Results
Feb 21, 2017 12:01 pm UTC| Business
CHATTANOOGA, Tenn., Feb. 21, 2017 -- Astec Industries, Inc. (Nasdaq:ASTE) today reported results for their fourth quarter and year ended December 31, 2016. Net sales for the fourth quarter of 2016 were $326.6 million...
Scripps Networks Interactive reports full year and fourth quarter 2016 operating results
Feb 21, 2017 12:00 pm UTC| Business
Full Year 2016 Financial Highlights: Record consolidated operating revenues of $3.4 billion, an increase of 12.7%;Record consolidated advertising revenues of $2.4 billion, an increase of 17.2%;Consolidated operating...
Bellicum Announces Initiation of Patient Dosing with Controllable CAR T-Cell Product Candidate
Feb 21, 2017 12:00 pm UTC| Business
HOUSTON, Feb. 21, 2017 -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced it has dosed...
Feb 21, 2017 12:00 pm UTC| Business
– Program is on track for NDA submission in 4Q 2017 – – OLINVOTM to be the proprietary brand name for oliceridine –– Company to host conference call and webcast at 8:00 a.m. EST – KING OF PRUSSIA, Pa., Feb. 21, 2017 ...
Feb 21, 2017 12:00 pm UTC| Business
TEL AVIV, Israel, Feb. 21, 2017 -- VBL Therapeutics (NASDAQ:VBLT), announced today full results from its exploratory Phase 2 study of VB-111 (ofranergene obadenovec) in patients with advanced, differentiated thyroid...
Trump Says Ukraine Peace Deal ‘Closer,’ But Key Disputes Remain Unresolved